Atai life sciences announces positive initial results for phase 1 trial of kur-101, an oral formulation of mitragynine for oud

– initial results showed that single ascending oral dosing of kur-101 produces dose-dependent analgesia (pain relief) with effects on respiration comparable to that of placebo.

ATAI Ratings Summary

ATAI Quant Ranking